These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 6504897)

  • 21. [Management of Ta, T1, and in situ bladder carcinoma: what is new?].
    Irani J
    Prog Urol; 2008 May; 18 Suppl 5():S94-8. PubMed ID: 18585634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [BCG therapy. Its role in the treatment of tumors of the bladder].
    Patard JJ; Chopin DK; Abbou CC
    Ann Urol (Paris); 1995; 29(5):292-3. PubMed ID: 8638911
    [No Abstract]   [Full Text] [Related]  

  • 23. Intravesical therapy for superficial bladder cancer.
    Malkowicz SB
    Semin Urol Oncol; 2000 Nov; 18(4):280-8. PubMed ID: 11101091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of superficial bladder carcinoma with BCG. Long term follow-up.
    Martínez-Piñeiro JA
    Prog Clin Biol Res; 1984; 162B():335-45. PubMed ID: 6438642
    [No Abstract]   [Full Text] [Related]  

  • 25. Valrubicin: an alternative to radical cystectomy for carcinoma in situ of the bladder.
    Randall S
    Urol Nurs; 2001 Feb; 21(1):30-1, 34-6. PubMed ID: 11998112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radical cystectomy after bacillus Calmette-Guérin for high-risk Ta, T1, and carcinoma in situ: defining the risk of initial bladder preservation.
    Nieder AM; Simon MA; Kim SS; Manoharan M; Soloway MS
    Urology; 2006 Apr; 67(4):737-41. PubMed ID: 16618564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BCG product approved for CIS of the bladder.
    Oncology (Williston Park); 1990 Jul; 4(7):106. PubMed ID: 2143934
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of bladder carcinoma in situ].
    Pegoraro V; Dal Bianco M; Bassi P; Prayer Galetti T; Cisternino A; Zattoni F
    J Urol (Paris); 1985; 91(1):43-5. PubMed ID: 4045205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The optimal management of T1G3 bladder cancer.
    Emiliozzi P; Pansadoro A; Pansadoro V
    BJU Int; 2008 Nov; 102(9 Pt B):1265-73. PubMed ID: 19035891
    [No Abstract]   [Full Text] [Related]  

  • 30. Low-dose BCG-Pasteur strain in the treatment of superficial bladder cancer: preliminary results.
    Pagano F; Bassi P; Milani C; Meneghini A; Tuccitto G; Garbeglio A; Guazzieri S
    Prog Clin Biol Res; 1989; 310():253-61. PubMed ID: 2672015
    [No Abstract]   [Full Text] [Related]  

  • 31. Percutaneous BCG perfusion of the upper urinary tract for carcinoma in situ.
    Studer UE; Casanova G; Kraft R; Zingg EJ
    Prog Clin Biol Res; 1989; 310():207-12. PubMed ID: 2771994
    [No Abstract]   [Full Text] [Related]  

  • 32. Management dilemmas in bladder cancer: radical TUR +/- systemic chemotherapy in the treatment of muscle-invasive bladder cancer.
    Feneley MR; Mellon JK
    Semin Urol Oncol; 2000 Nov; 18(4):300-7. PubMed ID: 11101094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical study of primary carcinoma in situ of the bladder].
    Mori Y; Shima H; Ihara H; Yabumoto H; Taguchi K; Koike H; Nojima M; Yamamoto H; Ikoma F
    Hinyokika Kiyo; 1996 Jan; 42(1):17-21. PubMed ID: 8686577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [BCG versus photodynamic therapy (PDT) for nonmuscle invasive bladder cancer-a multicentre clinical phase III study].
    Jocham D; von Wietersheim J; Pflüger H; Steiner H; Doehn C; Büttner H; Böhle A; Kausch I
    Aktuelle Urol; 2009 Mar; 40(2):91-9. PubMed ID: 19214951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Radical cystectomy for superficial tumors in the BCG era].
    Huguet Pérez J; Palou J; Millán Rodríguez F; Villavicencio Mavrich H; Rodríguez JV
    Arch Esp Urol; 2002; 55(1):50-6. PubMed ID: 11957752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Superficial bladder cancer--treatment approach.
    Abi-Aad A; Biquet P; Penders L
    Acta Urol Belg; 1996 May; 64(2):19-24. PubMed ID: 8701801
    [No Abstract]   [Full Text] [Related]  

  • 37. [In situ carcinoma of the bladder].
    González Martín M; Chantada Abal V; Lancina Martín JA; Forteza Vila J; Lamas Meilán AC; Yebra Pimentel MT
    Arch Esp Urol; 1985; 38(2):125-30. PubMed ID: 4026393
    [No Abstract]   [Full Text] [Related]  

  • 38. Resume of selected studies of the National Bladder Cancer Collaborative Group A and new protocols.
    Prout GR; Kopp J
    Prog Clin Biol Res; 1984; 162B():397-427. PubMed ID: 6438644
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of BCG with other intravesical agents.
    Lamm DL
    Urology; 1991; 37(5 Suppl):30-2. PubMed ID: 1826979
    [No Abstract]   [Full Text] [Related]  

  • 40. Ongoing trials in bladder cancer conducted by the EORTC Genito-Urinary Tract Cancer Cooperative Group.
    De Pauw M
    Prog Clin Biol Res; 1988; 260():215-23. PubMed ID: 3283760
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.